EUVIMEDEUVIMED entdecken
Crossref

Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell–related lung fibrosis by activating STAT5

Masaya Matsuda iD, Yuna Fujiwara, Fumiya Yonezawa, Kyoka Matsuo, Emi Ishizu, Hayato Shimora, Shun Shimizu, Kazuyuki Kitatani iD, Yuichiro Kaibori iD, Nobuyuki Yamagishi, Takuya Yashiro iD, Kazuyo Moro iD und 4 weitere

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Masaya Matsuda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan. Hauptthemen laut MEDLINE: STAT5 Transcription Factor, Lymphocytes, Cyclin-Dependent Kinases, Pulmonary Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Setsunan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group 2 innate lymphoid cells (ILC2s) produce large amounts of IL-5, IL-13, and amphiregulin, which are involved in the development of lung fibrosis. Activation of ILC2s is mediated by phosphorylation of STAT5. Although STAT5 has tyrosine and serine phosphorylation sites, the mechanisms responsible for phosphorylating serine residues and their significance in ILC2s remain unclear. The present study demonstrated that cyclin-dependent kinase (CDK) 8 and its paralog CDK19 (CDK8/19) were crucial for the activation of ILC2s in OVA-induced asthmatic BALB/c mice by phosphorylating serine residues of STAT5, leading to lung fibrosis. The following results were obtained: (1) The development of lung fibrosis and the number of ILC2s were significantly ameliorated by the CDK8/19 inhibitor, AS3334366, in OVA-induced asthmatic mice. Consistently, lung fibrosis did not develop in OVA-induced asthmatic ILC2-deficient (Il7rCre/+ Rorafl/fl) mice. (2) IL-33 markedly up-regulated the expression of IL-2 receptor chains, CD25 and CD132, in lung ILC2s. IL-2 significantly augmented the expression of ST2, the high-affinity receptor for IL-33. Furthermore, simultaneous stimulation with IL-33 and IL-2 resulted in the upregulation of CDK8/19 expression in ILC2s. (3) The combined treatment with IL-33 and IL-2 synergistically enhanced the proliferation and cytokine production of ILC2s. Conversely, both these effects, along with the phosphorylation of serine residues in STAT5, were suppressed by AS3334366 in a concentration-dependent manner. The present study is the first to report the involvement of CDK8/19 in the activation of ILC2s via the phosphorylation of STAT5, which led to the development of lung fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT5 Transcription FactorLymphocytesCyclin-Dependent KinasesPulmonary FibrosisCyclin-Dependent Kinase 8AsthmaAnimalsMiceMice, Inbred BALB CImmunity, InnatePhosphorylationInterleukin-33Ovalbumin

Stichwörter der Autor:innen

cyclin-dependent kinase 8/19group 2 innate lymphoid celllung fibrosis

Substanzen

STAT5 Transcription FactorCyclin-Dependent KinasesCyclin-Dependent Kinase 8Interleukin-33Ovalbumin

Autor:innen und Institutionen

  • Laboratory of Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan.
  • Laboratory of Analytics for Biomolecules, Faculty of Pharmaceutical Science, Setsunan University, Osaka, Japan.
  • Laboratory for Innate Immune Systems, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.
  • Laboratory of Experimental Immunology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Masaya Matsuda, Kazuyuki Kitatani, Yuichiro Kaibori, Takuya Yashiro, Kazuyo Moro, Ryoji Kawakami, Norihisa Mikami, Shimon Sakaguchi, Takeshi Nabe

Förderung

  • Setsunan University

Zitieren

APA

Matsuda, M., Fujiwara, Y., Yonezawa, F., Matsuo, K., Ishizu, E., Shimora, H., Shimizu, S., Kitatani, K., Kaibori, Y., Yamagishi, N., Yashiro, T., Moro, K., Kawakami, R., Mikami, N., Sakaguchi, S., & Nabe, T. (2025). Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell–related lung fibrosis by activating STAT5. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf171

Vancouver

Matsuda M, Fujiwara Y, Yonezawa F, Matsuo K, Ishizu E, Shimora H, et al. Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell–related lung fibrosis by activating STAT5. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf171

BibTeX
@article{Matsuda2025,
  author = {Matsuda, Masaya and Fujiwara, Yuna and Yonezawa, Fumiya and Matsuo, Kyoka and Ishizu, Emi and Shimora, Hayato and Shimizu, Shun and Kitatani, Kazuyuki and Kaibori, Yuichiro and Yamagishi, Nobuyuki and Yashiro, Takuya and Moro, Kazuyo and Kawakami, Ryoji and Mikami, Norihisa and Sakaguchi, Shimon and Nabe, Takeshi},
  title = {Cyclin-dependent kinase (CDK) 8 and its paralog CDK19 develop group 2 innate lymphoid cell–related lung fibrosis by activating STAT5},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf171}
}
Kostenlos starten →